DE602004029707D1 - Verfahren zum nachweis von hepatitis-c-virus - Google Patents

Verfahren zum nachweis von hepatitis-c-virus

Info

Publication number
DE602004029707D1
DE602004029707D1 DE602004029707T DE602004029707T DE602004029707D1 DE 602004029707 D1 DE602004029707 D1 DE 602004029707D1 DE 602004029707 T DE602004029707 T DE 602004029707T DE 602004029707 T DE602004029707 T DE 602004029707T DE 602004029707 D1 DE602004029707 D1 DE 602004029707D1
Authority
DE
Germany
Prior art keywords
hcv
virus
treating
agent
samples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004029707T
Other languages
English (en)
Inventor
Katsumi Aoyagi
Kumiko Iida
Naoko Matsubara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Life Science Institute Inc
Original Assignee
Advanced Life Science Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34510313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004029707(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advanced Life Science Institute Inc filed Critical Advanced Life Science Institute Inc
Publication of DE602004029707D1 publication Critical patent/DE602004029707D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109Hepatitis C virus; Hepatitis G virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602004029707T 2003-10-28 2004-10-28 Verfahren zum nachweis von hepatitis-c-virus Active DE602004029707D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003367783 2003-10-28
PCT/JP2004/016377 WO2005040815A1 (ja) 2003-10-28 2004-10-28 C型肝炎ウイルスの検出方法

Publications (1)

Publication Number Publication Date
DE602004029707D1 true DE602004029707D1 (de) 2010-12-02

Family

ID=34510313

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004029707T Active DE602004029707D1 (de) 2003-10-28 2004-10-28 Verfahren zum nachweis von hepatitis-c-virus

Country Status (11)

Country Link
US (1) US8546075B2 (de)
EP (1) EP1691198B1 (de)
JP (1) JP4744298B2 (de)
KR (2) KR20070108284A (de)
CN (2) CN101892199A (de)
AT (1) ATE485519T1 (de)
CA (1) CA2544185C (de)
DE (1) DE602004029707D1 (de)
HK (1) HK1094037A1 (de)
TW (1) TWI344002B (de)
WO (1) WO2005040815A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE493659T1 (de) * 2004-05-19 2011-01-15 Advanced Life Science Inst Inc Verfahren zum nachweis von hepatitis-b-virus
JP2009018990A (ja) * 2005-10-25 2009-01-29 Univ Kurume C型肝炎ウイルス由来ペプチド
US20090280474A1 (en) * 2008-05-08 2009-11-12 Abbott Laboratories Method for detecting a virus
JP5618570B2 (ja) * 2010-02-26 2014-11-05 シスメックス株式会社 C型肝炎ウイルスの免疫測定方法及びそれに用いる試薬キット
JP5351724B2 (ja) * 2009-11-30 2013-11-27 シスメックス株式会社 C型肝炎ウイルスのコア蛋白の検出方法及び検出用試薬キット
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
BR112013005518A2 (pt) * 2010-09-07 2016-05-03 Smart Biotech método para detectar anticorpos específicos de vírus em uma amostra, método para diagnosticar uma infecção viral, método para aumentar os baixos níveis de anticorpos antivirais em uma amostra de sangue complera e kit para a detecção de anticorpos especificos de vírus expressos em níveis baixos em um indivíduo
JP6641841B2 (ja) * 2015-09-29 2020-02-05 富士レビオ株式会社 ヒトパルボウイルスb19抗原の測定方法
KR102165623B1 (ko) * 2016-05-31 2020-10-15 에프. 호프만-라 로슈 아게 바이러스 항원의 혈청학적 탐지 방법
JP7044721B2 (ja) * 2016-05-31 2022-03-30 エフ.ホフマン-ラ ロシュ アーゲー Hcvコア抗原の迅速な検出のための前処理法
US11768209B2 (en) * 2016-09-06 2023-09-26 Fujirebio Inc. Method and reagent for measuring thyroglobulin
WO2018047793A1 (ja) 2016-09-06 2018-03-15 富士レビオ株式会社 腫瘍マーカーの測定方法及び測定試薬
JP6999561B2 (ja) * 2016-09-13 2022-02-10 富士レビオ株式会社 心筋トロポニンの測定方法及び測定試薬
JP6801381B2 (ja) * 2016-11-07 2020-12-16 東ソー株式会社 凍結乾燥状態の検体前処理試薬
JP6601932B2 (ja) * 2017-03-27 2019-11-06 日本ハム株式会社 体液による抗原抗体反応阻害を防止する物質
CN111108193A (zh) 2017-09-18 2020-05-05 拜耳医药保健有限公司 使用n-甲基葡糖酰胺及其衍生物灭活病毒的方法
WO2019219154A1 (en) * 2018-05-14 2019-11-21 Abd El Motaleb Mohammed Abd Allah Taha Separation of antigens and hcv by diluted acids
CN110794149B (zh) * 2019-11-28 2023-05-12 南京迪安医学检验所有限公司 一种丙型肝炎病毒抗体的检测试剂
WO2022154119A1 (ja) * 2021-01-18 2022-07-21 富士レビオ株式会社 可溶性gpc3のイムノアッセイにおける可溶性gpc3含有検体の処理方法
CN113552358A (zh) * 2021-09-03 2021-10-26 郑州安图生物工程股份有限公司 一种hcv病毒裂解剂及其制备方法、hcv病毒检测试剂盒

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527489B2 (en) 1978-03-20 1983-03-10 Abbott Laboratories Sugar coated reagents for solid phase immunoassay
US4609630A (en) 1983-03-23 1986-09-02 Yanovsky Jorge F Method for improving the specificity of immunoassays
US4703001A (en) 1985-10-23 1987-10-27 Synbiotics, Corporation Immunoassay for the detection of serum analytes using pH dependent chastropic acids
DE3718140A1 (de) 1987-05-29 1988-12-08 Boehringer Mannheim Gmbh Heterogener immunoassay
CH673407A5 (de) 1987-06-24 1990-03-15 Sulzer Ag
US5151370A (en) 1990-10-11 1992-09-29 Synermed, Inc. Reagent and method for serum iron assay
KR950704354A (ko) * 1992-12-07 1995-11-20 에프.쥐.엠, 헤르만스 페.카.브론스 씨(c)형 간염 바이러스(hcv)씨(c)33 영역 유래의 펩티드, 이에 대한 항체 및 씨(c)형 간염 바이러스를 검출하는 방법(peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv)
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
JPH0862219A (ja) 1994-08-19 1996-03-08 Dainabotsuto Kk 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法
US5616460A (en) 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
JP3176570B2 (ja) 1997-08-04 2001-06-18 株式会社先端生命科学研究所 Hcvの検出又は測定方法
CA2267207C (en) 1997-08-04 2008-10-28 Tonen Corporation Methods for detecting or assaying virus
JP3171827B2 (ja) * 1997-08-04 2001-06-04 株式会社先端生命科学研究所 ウイルスの検出又は測定方法
ES2316171T3 (es) 1997-09-22 2009-04-01 Novartis Vaccines And Diagnostics, Inc. Tampones para estabilizar antigenos hcv.
DK1471074T3 (da) 1998-04-17 2008-11-17 Innogenetics Nv Fremgangsmåder til forbedring af konformationen af proteiner ved hjælp af reduktionsmidler
US6393260B1 (en) * 1998-04-17 2002-05-21 Nokia Mobile Phones Limited Method for attenuating spurious signals and receiver
BR9906660A (pt) * 1998-07-30 2000-08-29 Advanced Life Science Inst Inc Processo para medir vìrus da hepatite c
FR2791138B1 (fr) 1999-03-19 2001-04-27 Abx Sa Reactif pour la determination des leucocytes et la mesure de l'hemoglobine dans un echantillon de sang
US20020037868A1 (en) * 1999-04-14 2002-03-28 Institut Pasteur Method for detecting hepatitis C
JP4298850B2 (ja) 1999-06-24 2009-07-22 シスメックス株式会社 C型肝炎ウィルス(hcv)検出方法
KR100340046B1 (ko) * 1999-11-01 2002-06-12 오길록 다중 대역 및 다중 모드용 주파수 변환 수신기
WO2002010744A1 (fr) 2000-08-01 2002-02-07 International Reagents Corporation Procede pour pretraiter un echantillon
US7101683B2 (en) * 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies

Also Published As

Publication number Publication date
CN1871518B (zh) 2010-08-25
CN101892199A (zh) 2010-11-24
CA2544185C (en) 2010-09-28
TW200526959A (en) 2005-08-16
US8546075B2 (en) 2013-10-01
ATE485519T1 (de) 2010-11-15
JPWO2005040815A1 (ja) 2007-04-26
KR20070108284A (ko) 2007-11-08
KR100830723B1 (ko) 2008-05-20
CN1871518A (zh) 2006-11-29
EP1691198A1 (de) 2006-08-16
US20080044807A1 (en) 2008-02-21
HK1094037A1 (en) 2007-03-16
TWI344002B (en) 2011-06-21
KR20060061400A (ko) 2006-06-07
EP1691198A4 (de) 2008-03-05
JP4744298B2 (ja) 2011-08-10
WO2005040815A1 (ja) 2005-05-06
EP1691198B1 (de) 2010-10-20
CA2544185A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
HK1094037A1 (en) Method of detecting hepatitis c virus
ATE493659T1 (de) Verfahren zum nachweis von hepatitis-b-virus
DE50105898D1 (de) Verfahren zum Herstellen von Seitenfaltensäcken aus Kunststofffolie
ATE465742T1 (de) Tlr7-liganden zur behandlung von hepatitis c
DE602005016895D1 (de) Verfahren zum Behandeln von Wäschestücken
ATE483738T1 (de) Verfahren zur herstellung von copolymeren in gegenwart eines kettenübertragungsmittel
ATE293155T1 (de) Verfahren zur verhütung von verschmutzung und korrosion durch ammoniumchlorid und ammoniumsulfat
DE60228194D1 (de) Verfahren und vorrichtung zum schnellen aufheizen von nmr-proben
DE69923278D1 (de) Verfahren zum herstellen von zusammenhängenden beuteln
ATE269529T1 (de) Verfahren zur behandlung von abgasen in der stahlindustrie
DE60136355D1 (de) Verfahren zum entwickeln von werkzeugen
DE50104569D1 (de) Verfahren zum behandeln von tabak
ATE354694T1 (de) Verfahren zum behandeln von textilien
DE60207938T2 (de) Verfahren zum Herstellen von wiederverschliessbaren Kunststoffbeuteln
DE69915833D1 (de) Verfahren zur wiedergewinnung von acrylonitril
ATE485381T1 (de) Verfahren zur einführung eines gens in pflanzenmaterial
DE69911853D1 (de) Verfahren zum Dauerappretieren von Textilien
ATE455845T1 (de) Verfahren zur herstellung von substanzen
ATE292557T1 (de) Verfahren zum herstellen von kunststoffbeuteln
DE602004015454D1 (de) Verfahren und vorrichtung zur kontinuierlichen radioaktiven markierung von proteinen im grossen massstab
DE60201984D1 (de) Werkzeugstahl von hoher zähigkeit, verfahren zum herstellen von teilen aus diesem stahl und so hergestellte teile
DE60112171D1 (de) Verfahren zur Behandlung eines eine SO3-Komponente enthaltenden Gases mit Na2CO3
ATE370411T1 (de) Verfahren zum screening
ATE465752T1 (de) Verfahren zur gewinnung delipidierter antigener aggregate von hepatitis b und deren verwendung
DE50105330D1 (de) Verfahren zum herstellen von flachbandkabeln